The privately held company, CardiAQ Valve Technologies, is focused on developing innovative approaches to heart valve replacement. Their system enables physicians to implant a new mitral valve within a beating heart, avoiding the need for open-heart surgery. The procedure can be performed in a cardiac catheterization laboratory or hybrid operating room, similar to angioplasty or stenting. This approach reduces trauma to the patient and has the potential for significant cost-savings in the healthcare system.